Peg IFN-α-2b Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Top Sponsors

First Affiliated Hospital Xi'an Jiaotong University1

Indications

Liver Disease1
Hepatitis B Virus (HBV)1
Hepatitis B1
Hepatitis B, Chronic (CHB)1
Liver Cancer1

Other1 trial

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.